ÂÜÀòÂÒÂ×

The Leadership Team at NEOGAP Therapeutics AB is responsible for strategic direction and decision-making to drive the company's mission in immuno-oncology. Comprising executives with expertise in business operations, scientific research, and clinical development, the team aligns resources and priorities to advance the development of personalized tumor trained lymphocyte therapies, ensuring innovative solutions in cancer treatment while maintaining a focus on patient safety and efficacy.